Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2025-11-19Clinical Trial Update: Intermittent Intrapulmonary Deflation and Dyspnea Following Exercise in People With Chronic Obstructive Pulmonary Disease [NA]
A clinical trial update for a study on intermittent intrapulmonary deflation and exercise-induced dyspnea in people with Chronic Obstructive…
-
EMA approval · 2025-11-18EMA Authorised: Oslif Breezhaler (indacaterol maleate) — Novartis Europharm Limited
The European Medicines Agency authorised Oslif Breezhaler (indacaterol maleate) for chronic obstructive pulmonary disease; decision date 18 …
-
EMA approval · 2025-11-18EMA Authorised: Onbrez Breezhaler (indacaterol maleate) — Novartis Europharm Limited
EU marketing authorization granted for Onbrez Breezhaler (indacaterol maleate) for chronic obstructive pulmonary disease.
-
EMA approval · 2025-11-18EMA Authorised: Hirobriz Breezhaler (indacaterol maleate) — Novartis Europharm Limited
EMA has authorised Hirobriz Breezhaler containing indacaterol maleate for chronic obstructive pulmonary disease (COPD).
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Evaluation of 611 in Chinese Adults Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease [Phase 3]
A Phase 3 clinical trial evaluating the compound 611 in Chinese adults with moderate to severe chronic obstructive pulmonary disease is curr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Frequency-time Analysis of Pathological Lung Sounds: Detection and Quantification of Pathological Sounds in Patients With Cystic Fibrosis, Pulmonary Fibrosis or COPD (Chronic Obstructive Pulmonary Disease)
A clinical trial examining frequency-time analysis of pathological lung sounds in patients with cystic fibrosis, pulmonary fibrosis, or chro…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Controlled Breathing Intervention to Reduce Stress and Improve Symptoms in COPD Patients (REST) [NA]
The REST study, a controlled breathing intervention for COPD patients to reduce stress and improve dyspnea-related symptoms, has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: Pulmonary Specialist-Health Coach Consult Model Study [NA]
Completed clinical trial evaluating a pulmonary specialist health coach consult model for COPD and asthma; results posted 2025-11-14.
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: Mesenchymal Stem Cells in the Treatment of Subjects With Advance Chronic Obstructive Pulmonary Disease (COPD) [Phase 1]
A Phase 1 clinical trial evaluating mesenchymal stem cells in subjects with advanced chronic obstructive pulmonary disease has completed; th…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
Clinical trial update indicating ongoing collection of airway, blood, and/or urine specimens from participants for research studies.
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: Study of COPD Subgroups and Biomarkers
A clinical trial update indicates an active-not-recruiting study on COPD subgroups and biomarkers run by University of North Carolina at Cha…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Rural Hospital-Level Care at Home for Acutely Ill Adults [NA]
This clinical trials.gov entry notes that the Brigham and Women's Hospital study on rural hospital-level care at home for acutely ill adults…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Nurse Coach-Led Early Palliative Care for Older Adults With COPD and Their Care Partners: The Project EPIC Pilot RCT [NA]
The Project EPIC pilot randomized controlled trial evaluated nurse coach–led early palliative care for older adults with chronic obstructive…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency [Phase 4]
A Phase 4 clinical trial investigating the role of immunoglobulin G genetic variation in individuals with Alpha-1 antitrypsin deficiency and…
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD [Phase 1]
A Phase 1 clinical trial update for GB-0895 in adults with asthma or chronic obstructive pulmonary disease is ongoing. The study status is A…
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: Study of ARO-MUC5AC in Healthy Subjects and Patients With Muco-Obstructive Lung Disease [Phase 1, Phase 2]
The study of ARO-MUC5AC in healthy subjects and patients with muco-obstructive lung disease (asthma and COPD) has been terminated.
-
CLINICAL_TRIALS research · 2025-11-03Clinical Trial Update: Validation of Chronic Obstructive Pulmonary Disease (COPD) Algorithm
A Wake Forest trial is validating a COPD algorithm, with patient recruitment currently ongoing.
-
CLINICAL_TRIALS trial_result · 2025-11-03Clinical Trial Update: Acupuncture to Enhance for Pulmonary Rehab [NA]
A study evaluating acupuncture as an adjunct to pulmonary rehabilitation for chronic obstructive pulmonary disease has been terminated, with…
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia [Phase 2]
A Phase 2 clinical trial is evaluating inhaled treprostinil delivered by Tyvaso nebulizer for COPD patients with hypoxemia; the study is cur…
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD [NA]
The Cleveland Clinic reports the implementation of a Sarcopenia Clinic to diagnose and treat skeletal muscle loss in COPD patients, with rec…
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: MOBoxy: MoblO2 to Maintain Oxygenation [NA]
This clinical trial update describes a study of MOBoxy (MoblO2) intended to maintain oxygenation in patients with COPD and interstitial lung…
-
CLINICAL_TRIALS trial_result · 2025-10-29Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Oral AZD6793 in Healthy and Chronic Obstructive Pulmonary Disease Participants, to Assess the Relative Oral Bioavailability Between Two Formulations, and the Food Effect on the PK of AZD6793 Compared to Fasting State. [Phase 1]
A Phase 1 study evaluating the safety, tolerability, pharmacokinetics, and relative oral bioavailability of AZD6793 in healthy participants …
-
CLINICAL_TRIALS research · 2025-10-27Clinical Trial Update: Electronic Cigarette-derived Oxidants and Cardiopulmonary Effects [EARLY_Phase 1]
An early phase 1 clinical trial is evaluating the cardiopulmonary effects of oxidants generated by electronic cigarettes in people with chro…
-
CLINICAL_TRIALS withdrawal · 2025-10-24Clinical Trial Update: Heat Waves and the Elderly With COPD [NA]
A clinical trial sponsored by the University of Texas Southwestern Medical Center evaluating heat waves effects in elderly patients with chr…
-
CLINICAL_TRIALS research · 2025-10-24Clinical Trial Update: Acoustic Waveform Respiratory Evaluation [NA]
This clinical trial evaluates acoustic waveform respiratory assessment across several respiratory diseases and is currently recruiting.